Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease

New England Journal of Medicine

Volumn 318, Issue 14, 1988, Pages 876-880

  Kish, Stephen J ^a   Shannak, Kathleen ^a   Hornykiewicz, Oleh ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

AUTOPSY; CORPUS STRIATUM; HISTOLOGY; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ADRENAL MEDULLA; AGED; CAUDATE NUCLEUS; CORPUS STRIATUM; DOPAMINE; HUMAN; PARKINSON DISEASE; PUTAMEN; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0023874410     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198804073181402     Document Type: Article

References (32)

1. Bjorklund A, Stenevi U, eds. Neural grafting in the mammalian CNS. Amsterdam: Elsevier Press, 1985.
2. Olson L, Backlund EO, Gerhardt G, et al. Nigral and adrenal grafts in Parkinsonism: recent basic and clinical studies. In: Yahr MD, Bergmann KJ, eds. Advances in neurology. Vol. 45. New York: Raven Press, 1986:85–94.
3. Madrazo I, Drucker-Colín R, Días V, Martínez-Mata J, Torres C, Becerril JJ, Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 1987; 316: 831–4.
4. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357–81.
5. Graybiel AM, Ragsdale CW. Biochemical anatomy of the striatum. In: Emsom PC, ed. Chemical neuroanatomy. New York: Raven Press, 1983.
6. Goldman-Rakic PS, Selemon LD. Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum. In: Jones EG, Peters A, eds. Cerebral cortex. Vol. 5. New York: Plenum Press, 1986.
7. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20: 415–55.
8. Poirier LJ, Sourkes TL, Bouvier G, Boucher R, Carabin S. Striatal amines, experimental tremor and the effect of harmaline in the monkey. Brain 1966; 89: 37–52.
9. Iversen S. Dopamine depletion and replacement. In: Evered D, O'Connor M, eds. Functions of the basal ganglia: CIBA Foundation Symposium 107. London: Pitman, 1984:216–21.
10. Donnan GA, Willis GL, Kaczmarczyk SJ, Rowe P. Motor function in the l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-treated mouse. J Neurol Sci 1987; 77: 185–91.
11. Hassler R. Zur pathologic der Paralysis agitans und des postenzephaiiti-schen Parkinsonismus. J Psychol Neurol 1938; 48: 387–476.
12. Felice LJ, Felice JD, Kissinger PT. Determination of catccholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 1978; 31: 1461–5.
13. Nyberg P. Nordberg A, Wester P, Winblad B. Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease. Neurochem Pathol 1983; 1: 193–202.
14. Marsden CD. The enigma of the basal ganglia and movement. Trends Neurosci 1980; 3: 284–7.
15. Homykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1986; 45: 19–34.
16. Crutcher MD, DeLong MR. Single cell studies of the primate putamen. I. Functional organization. Exp Brain Res 1984; 53: 233–43.
17. Crutcher. Single cell studies of the primate putamen. II. Relations to direction of movement and pattern of muscular activity. Exp Brain Res 1984; 53: 244–58.
18. Künzle H. Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia: an autoradiographic study in Macaca fascicularis. Brain Res 1975; 88: 195–209.
19. Künzle. Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey. Exp Brain Res 1977; 30: 481–92.
20. Künzle. An autoradiographic analysis of the efferent connections from premotor and adjacent prefrontal regions (areas 6 and 9) in macaca fascicularis. Brain Behav Evol 1978; 15: 185–234.
21. DeLong MR, Strick PL. Relation of basal ganglia, cerebellum, and motor cortex units to ramp and ballistic limb movements. Brain Res 1974; 71: 327–35.
22. Jones EG, Coulter JD, Burton H, Porter R. Cells of origin and terminal distribution of corticostriatal fibers arising in the sensory-motor cortex of monkeys. J Comp Neurol 1977; 173: 53–80.
23. DeLong MR, Georgopoulos AP, Crutcher MD. Cortico-basal ganglia relations and coding of motor performance. Exp Brain Res 1983; Suppl 7: 29–40.
24. Evarts EV, Kimura M, Wurtz RH, Hikosaka O. Behavioral correlates of activity in basal ganglia neurons. Trends Neurosci 1984; 7: 447–53.
25. Goldman PS, Nauta WJH. An intricately patterned prefronto-caudate projection in the rhesus monkey. J Comp Neurol 1977; 171: 369–86.
26. Taylor AE, Saint-Cyr JA. Lang AE. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 1986; 109: 845–83.
27. Gotham A-M, Brown RG, Marsden CD. Levodopa treatment may benefit or impair “frontal” function in Parkinson's disease. Lancet 1986; 2: 970–1.
28. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257–70.
29. Kish SJ, Chang LI, Mirchandani L. Shannak K, Hornykiewicz O. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain ne uro transmitter markers. Ann Neurol 1985; 18: 530–6.
30. Kish SJ, Gilbert JJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Ann Neurol 1985; 17: 405–7.
31. Kesslak JP, Nieto-Sampedro M, Globus J, Colman CW. Transplants of purified astrocytes promote behavioral recovery after frontal cortex ablation. Exp Neurol 1986; 92: 377–90.
32. Moore RY. Parkinson's disease — A new therapy? N Engl J Med 1987; 316: 872–3.